GSK puts further investment into Cork

GlaxoSmithKline (GSK) is set to invest a further $19m (€15.5m) in its research facility in Carrigaline, Cork.

Fri, 12 Dec, 2003 - 08:19

GlaxoSmithKline (GSK) is set to invest a further $19m (€15.5m) in its research facility in Carrigaline, Cork.

The drug giant will use the money to build a new pharmaceutical R&D facility that will create 10 highly skilled jobs.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Kerry's Eye newspaper acquired by printing firm Webprint Kerry's Eye newspaper acquired by printing firm Webprint
National Fuel Protest IMF warns EU not to shield consumers and businesses from energy price spike 
Sudan War Intense focus on Middle East means suffering in Sudan 
CourtsBusinessHeathrowPlace: Carrigaline, CorkPlace: IrelandPlace: CorkOrganisation: GSKOrganisation: Glaxosmithkline
<p>Cork-founded information and communication technologies company PFH Technology has posted turnover of €178.5m, up 18% on the previous year, with operating profits increasing to €19.8m.</p>

Profits rise to €19.8m at Cork-headquartered PFH Technology

READ NOW

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Latest

Business

Push Notifications

By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.

Sign Up
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Fergus Finlay
Fergus Finlay

Analysis

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited